Q-omics provides the consensus-scored SNORD24 profile across patient tissues and cancer cell-line models. Additionally, SNORD24 RNA expression shows 1 significant drug associations, with the highest sampling consensus in Triple_Negative_Breast_Cancer.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for SNORD24 — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Cross-omics associations

This table shows molecular features associated with SNORD24 in patient tissues and cancer cell lines. In patient samples, SNORD24 shows the broadest associations at the RNA and protein expression levels, with Triple_Negative_Breast_Cancer recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Drug	1	Triple_Negative_Breast_Cancer (1)	view →